Bio-Techne (TECH) CEO nets shares after stock option exercise

robot
Abstract generation in progress

Bio-Techne CEO Kim Kelderman recently exercised 11,344 stock options, acquiring shares of Bio-Techne common stock. This compensation-related activity also involved the disposal of 1,363 shares to cover tax obligations. After these transactions, Kelderman directly holds 63,058 common shares, with additional substantial equity incentives remaining.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin